Infectivity of exhaled SARS-CoV-2 aerosols is sufficient to transmit covid-19 within minutes.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
01 Dec 2023
01 Dec 2023
Historique:
received:
20
09
2023
accepted:
18
11
2023
medline:
4
12
2023
pubmed:
2
12
2023
entrez:
1
12
2023
Statut:
epublish
Résumé
Exhaled SARS-CoV-2-containing aerosols contributed significantly to the rapid and vast spread of covid-19. However, quantitative experimental data on the infectivity of such aerosols is missing. Here, we quantified emission rates of infectious viruses in exhaled aerosol from individuals within their first days after symptom onset from covid-19. Six aerosol samples from three individuals were culturable, of which five were successfully quantified using TCID
Identifiants
pubmed: 38040798
doi: 10.1038/s41598-023-47829-8
pii: 10.1038/s41598-023-47829-8
pmc: PMC10692216
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
21245Subventions
Organisme : Wellcome Trust
ID : 220077
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 200109
Pays : United Kingdom
Informations de copyright
© 2023. The Author(s).
Références
Int J Environ Res Public Health. 2021 Mar 12;18(6):
pubmed: 33809366
Clin Infect Dis. 2020 Dec 17;71(10):2663-2666
pubmed: 32442256
Science. 2021 Jan 15;371(6526):
pubmed: 33234698
J R Soc Interface. 2009 Dec 6;6 Suppl 6:S737-46
pubmed: 19773291
BMJ. 2022 Jun 29;377:e068743
pubmed: 35768139
PLoS One. 2022 Nov 17;17(11):e0277699
pubmed: 36395156
Proc Natl Acad Sci U S A. 2022 Jul 19;119(29):e2208742119
pubmed: 35858364
PLoS One. 2022 Jun 9;17(6):e0265816
pubmed: 35679278
J Aerosol Sci. 2022 Sep;165:106038
pubmed: 35774447
Infect Dis (Lond). 2023 Feb;55(2):158-163
pubmed: 36331347
iScience. 2022 Sep 16;25(9):105000
pubmed: 36035197
Clin Infect Dis. 2022 Aug 24;75(1):e241-e248
pubmed: 34519774
Int J Infect Dis. 2020 Nov;100:476-482
pubmed: 32949774
Food Environ Virol. 2011 Mar;3(1):1-30
pubmed: 35255645
EMBO Mol Med. 2022 Feb 7;14(2):e15290
pubmed: 34862752
BMJ Open. 2021 Jun 28;11(6):e041240
pubmed: 34183334
Clin Infect Dis. 2022 May 30;74(10):1722-1728
pubmed: 34358292
EMBO J. 2021 Dec 15;40(24):e108944
pubmed: 34601723
JAMA Netw Open. 2021 Jan 4;4(1):e2035057
pubmed: 33410879
Proc Natl Acad Sci U S A. 2020 Mar 31;117(13):7001-7003
pubmed: 32165541
Clin Infect Dis. 2022 Aug 24;75(1):e50-e56
pubmed: 35271734
J Infect. 2008 Nov;57(5):361-73
pubmed: 18848358
Proc Natl Acad Sci U S A. 2022 Jul 5;119(27):e2200109119
pubmed: 35763573
Nat Med. 2022 May;28(5):1031-1041
pubmed: 35361992
Int J Infect Dis. 2023 Jan;126:73-78
pubmed: 36356797
Clin Infect Dis. 2023 Mar 4;76(5):786-794
pubmed: 36285523
Gut Pathog. 2022 Aug 20;14(1):35
pubmed: 35987708
Euro Surveill. 2020 Aug;25(32):
pubmed: 32794447
Ann Intern Med. 2021 Jan;174(1):69-79
pubmed: 32941052